{"version":"1.0","provider_name":"Cilcare","provider_url":"https:\/\/www.cilcare.com\/jp","title":"CILcare and Amylgen partner against Alzheimer's disease - Cilcare","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"j93f0bdiy8\"><a href=\"https:\/\/www.cilcare.com\/jp\/2018\/06\/21\/cilcare-amylgen-partner\/\">CILcare and Amylgen partner against Alzheimer&#8217;s disease<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.cilcare.com\/jp\/2018\/06\/21\/cilcare-amylgen-partner\/embed\/#?secret=j93f0bdiy8\" width=\"600\" height=\"338\" title=\"&#8220;CILcare and Amylgen partner against Alzheimer&#8217;s disease&#8221; &#8212; Cilcare\" data-secret=\"j93f0bdiy8\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.cilcare.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>","thumbnail_url":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2018\/06\/AMYLGEN-CILCARE_2017-05-22.png","thumbnail_width":1024,"thumbnail_height":684,"description":"Age-related disorders, CILcare and Amylgen partner to propose unique preclinical models to assess the effects of health solutions on hearing and cognitive functions ! It is established that hearing loss is one of the three major risk factors for dementia and is clearly linked to Alzheimer&#8217;s disease, which affects nearly 25 million people around the world, while 466 million people have hearing loss. CILcare, the world- leading CRO specializing in hearing disorders and Amylgen, CRO specializing in neurodegenerative disorders, have decided to combine their expertise to propose unique preclinical tests, which assess both hearing loss and cognitive decline. \u201cThe exploration of the relationship between hearing loss and the onset of [&hellip;]"}